RESEARCH ARTICLE G1/S cell cycle regulators mediate effects of circadian dysregulation on tumor growth and provide targets for timed anticancer treatment 1 2 1 1 3 Yool Lee , Nicholas F. LahensID , Shirley ZhangID , Joseph Bedont , Jeffrey M. Field , 1 Amita SehgalID * 1 Penn Chronobiology, Howard Hughes Medical Institute, Department of Neuroscience, Perelman School of a1111111111 Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, 2 Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, a1111111111 Philadelphia, Pennsylvania, United States of America, 3 Department of Systems Pharmacology and a1111111111 Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, a1111111111 Pennsylvania, United States of America a1111111111 *
[email protected] Abstract OPEN ACCESS Citation: Lee Y, Lahens NF, Zhang S, Bedont J, Circadian disruption has multiple pathological consequences, but the underlying mecha- Field JM, Sehgal A (2019) G1/S cell cycle nisms are largely unknown. To address such mechanisms, we subjected transformed cul- regulators mediate effects of circadian tured cells to chronic circadian desynchrony (CCD), mimicking a chronic jet-lag scheme, dysregulation on tumor growth and provide targets and assayed a range of cellular functions. The results indicated a specific circadian clock± for timed anticancer treatment. PLoS Biol 17(4): e3000228. https://doi.org/10.1371/journal. dependent increase in cell proliferation. Transcriptome analysis revealed up-regulation of pbio.3000228 G1/S phase transition genes (myelocytomatosis oncogene cellular homolog [Myc], cyclin Academic Editor: Achim Kramer, Charite - D1/3, chromatin licensing and DNA replication factor 1 [Cdt1]), concomitant with increased UniversitaÈtsmedizin Berlin, GERMANY phosphorylation of the retinoblastoma (RB) protein by cyclin-dependent kinase (CDK) 4/6 Received: September 20, 2018 and increased G1-S progression.